Literature DB >> 2161978

Distribution of Lipiodol in hepatocellular carcinoma.

C Park1, S I Choi, H Kim, H S Yoo, Y B Lee.   

Abstract

Intrahepatic distribution of Lipiodol and I-131 Lipiodol infused via the hepatic arteries was evaluated in six patients with HCC who had undergone hepatic lobectomy or segmentectomy. CT scan and gamma camera radiograph confirmed that the oily contrast material or I-131 radioactivity accumulated selectively in the tumor over a long period. One to two thirds of the tumor mass appeared necrotic, although the extent tended to be larger in the case of radioactive Lipiodol infusion. The tumor cells contained numerous lipid globules within the cytoplasm. Also, oil red 0 stain demonstrated that the individual tumor cells had non-globular lipid on their surface. In conclusion, Lipiodol leaks out of the vascular spaces to attach to the cancer cell membrane as a non-globular lipid as well as to enter the cancer cells as a globular lipid. This phenomenon specific to cancer cells suggests a biochemical membrane change which may have occurred during carcinogenesis, causing alteration of membrane transport and cell death.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161978     DOI: 10.1111/j.1600-0676.1990.tb00439.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  7 in total

1.  Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.

Authors:  Kostas Delaunay; Julien Edeline; Yan Rolland; Nicolas Lepareur; Sophie Laffont; Xavier Palard; Christelle Bouvry; Samuel Le Sourd; Marc Pracht; Valérie Ardisson; Nicolas Noiret; Éric Bellissant; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-04       Impact factor: 9.236

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma.

Authors:  Anne Hulin; Jeanick Stocco; Mohamed Bouattour
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

3.  Biodistribution of rhenium-188 Lipiodol infused via the hepatic artery of rats with hepatic tumours.

Authors:  S J Wang; W Y Lin; M N Chen; B T Hsieh; L H Shen; Z T Tsai; G Ting; F F Knapp
Journal:  Eur J Nucl Med       Date:  1996-01

4.  Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol.

Authors:  H S Yoo; C H Park; J T Lee; K W Kim; C S Yoon; J H Suh; C Y Park; B S Kim; H J Choi; K S Lee
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model.

Authors:  Johanna Maria Mijntje van Breugel; Jean-François Geschwind; Sahar Mirpour; Lynn Jeanette Savic; Xuchen Zhang; Rafael Duran; MingDe Lin; Milena Miszczuk; Eleni Liapi; Julius Chapiro
Journal:  Theranostics       Date:  2019-05-27       Impact factor: 11.556

Review 6.  Therapeutic Strategies in HCC: Radiation Modalities.

Authors:  R Gallicchio; A Nardelli; P Mainenti; A Nappi; D Capacchione; V Simeon; C Sirignano; F Abbruzzi; F Barbato; M Landriscina; G Storto
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

7.  Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.

Authors:  Yong Du; Angel Cortez; Anders Josefsson; Mohammadreza Zarisfi; Rebecca Krimins; Eleni Liapi; Jessie R Nedrow
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.